EUVIMEDEUVIMED entdecken
Crossref

Empagliflozin improves oxidative stress injury in the diabetic liver by regulating Nrf2 signaling

Xiaoyun Zhang

International Journal of Clinical and Experimental Medicine · 2025

DOI: 10.62347/ipjn8980 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical and Experimental Medicine, 2025. Verfasst von Xiaoyun Zhang. Die Arbeit nennt 28 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zhang, X. (2025). Empagliflozin improves oxidative stress injury in the diabetic liver by regulating Nrf2 signaling. International Journal of Clinical and Experimental Medicine. https://doi.org/10.62347/ipjn8980

Vancouver

Zhang X. Empagliflozin improves oxidative stress injury in the diabetic liver by regulating Nrf2 signaling. International Journal of Clinical and Experimental Medicine. 2025. doi:10.62347/ipjn8980

BibTeX
@article{Zhang2025,
  author = {Zhang, Xiaoyun},
  title = {Empagliflozin improves oxidative stress injury in the diabetic liver by regulating Nrf2 signaling},
  journal = {International Journal of Clinical and Experimental Medicine},
  year = {2025},
  doi = {10.62347/ipjn8980}
}
Kostenlos starten →